Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Muscarinic Acetylcholine Receptor M4 Market Growth 2022-2028

  • LP 4928351
  • 91 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Muscarinic Acetylcholine Receptor M4 will have significant change from previous year. According to our (LP Information) latest study, the global Muscarinic Acetylcholine Receptor M4 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Muscarinic Acetylcholine Receptor M4 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Muscarinic Acetylcholine Receptor M4 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Muscarinic Acetylcholine Receptor M4 market, reaching US$ million by the year 2028. As for the Europe Muscarinic Acetylcholine Receptor M4 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Muscarinic Acetylcholine Receptor M4 players cover Anavex Life Sciences Corp, AstraZeneca Plc, Heptares Therapeutics Ltd, and Karuna Pharmaceuticals Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Muscarinic Acetylcholine Receptor M4 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Tropicamide

ANAVEX-273

VU-0467154

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cognitive Disorders

Psychosis

Amnesia

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Anavex Life Sciences Corp

AstraZeneca Plc

Heptares Therapeutics Ltd

Karuna Pharmaceuticals Inc

NeuroHealing Pharmaceuticals Inc

Sumitomo Dainippon Pharma Co Ltd

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Muscarinic Acetylcholine Receptor M4 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Muscarinic Acetylcholine Receptor M4 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Muscarinic Acetylcholine Receptor M4 by Country/Region, 2017, 2022 & 2028

2.2 Muscarinic Acetylcholine Receptor M4 Segment by Type

2.2.1 Tropicamide

2.2.2 ANAVEX-273

2.2.3 VU-0467154

2.2.4 Others

2.3 Muscarinic Acetylcholine Receptor M4 Sales by Type

2.3.1 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2017-2022)

2.3.2 Global Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Muscarinic Acetylcholine Receptor M4 Sale Price by Type (2017-2022)

2.4 Muscarinic Acetylcholine Receptor M4 Segment by Application

2.4.1 Cognitive Disorders

2.4.2 Psychosis

2.4.3 Amnesia

2.4.4 Others

2.5 Muscarinic Acetylcholine Receptor M4 Sales by Application

2.5.1 Global Muscarinic Acetylcholine Receptor M4 Sale Market Share by Application (2017-2022)

2.5.2 Global Muscarinic Acetylcholine Receptor M4 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Muscarinic Acetylcholine Receptor M4 Sale Price by Application (2017-2022)

3 Global Muscarinic Acetylcholine Receptor M4 by Company

3.1 Global Muscarinic Acetylcholine Receptor M4 Breakdown Data by Company

3.1.1 Global Muscarinic Acetylcholine Receptor M4 Annual Sales by Company (2020-2022)

3.1.2 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Company (2020-2022)

3.2 Global Muscarinic Acetylcholine Receptor M4 Annual Revenue by Company (2020-2022)

3.2.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Company (2020-2022)

3.2.2 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Company (2020-2022)

3.3 Global Muscarinic Acetylcholine Receptor M4 Sale Price by Company

3.4 Key Manufacturers Muscarinic Acetylcholine Receptor M4 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Muscarinic Acetylcholine Receptor M4 Product Location Distribution

3.4.2 Players Muscarinic Acetylcholine Receptor M4 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Muscarinic Acetylcholine Receptor M4 by Geographic Region

4.1 World Historic Muscarinic Acetylcholine Receptor M4 Market Size by Geographic Region (2017-2022)

4.1.1 Global Muscarinic Acetylcholine Receptor M4 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Muscarinic Acetylcholine Receptor M4 Annual Revenue by Geographic Region

4.2 World Historic Muscarinic Acetylcholine Receptor M4 Market Size by Country/Region (2017-2022)

4.2.1 Global Muscarinic Acetylcholine Receptor M4 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Muscarinic Acetylcholine Receptor M4 Annual Revenue by Country/Region

4.3 Americas Muscarinic Acetylcholine Receptor M4 Sales Growth

4.4 APAC Muscarinic Acetylcholine Receptor M4 Sales Growth

4.5 Europe Muscarinic Acetylcholine Receptor M4 Sales Growth

4.6 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Growth

5 Americas

5.1 Americas Muscarinic Acetylcholine Receptor M4 Sales by Country

5.1.1 Americas Muscarinic Acetylcholine Receptor M4 Sales by Country (2017-2022)

5.1.2 Americas Muscarinic Acetylcholine Receptor M4 Revenue by Country (2017-2022)

5.2 Americas Muscarinic Acetylcholine Receptor M4 Sales by Type

5.3 Americas Muscarinic Acetylcholine Receptor M4 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Muscarinic Acetylcholine Receptor M4 Sales by Region

6.1.1 APAC Muscarinic Acetylcholine Receptor M4 Sales by Region (2017-2022)

6.1.2 APAC Muscarinic Acetylcholine Receptor M4 Revenue by Region (2017-2022)

6.2 APAC Muscarinic Acetylcholine Receptor M4 Sales by Type

6.3 APAC Muscarinic Acetylcholine Receptor M4 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Muscarinic Acetylcholine Receptor M4 by Country

7.1.1 Europe Muscarinic Acetylcholine Receptor M4 Sales by Country (2017-2022)

7.1.2 Europe Muscarinic Acetylcholine Receptor M4 Revenue by Country (2017-2022)

7.2 Europe Muscarinic Acetylcholine Receptor M4 Sales by Type

7.3 Europe Muscarinic Acetylcholine Receptor M4 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Muscarinic Acetylcholine Receptor M4 by Country

8.1.1 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Revenue by Country (2017-2022)

8.2 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales by Type

8.3 Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Muscarinic Acetylcholine Receptor M4

10.3 Manufacturing Process Analysis of Muscarinic Acetylcholine Receptor M4

10.4 Industry Chain Structure of Muscarinic Acetylcholine Receptor M4

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Muscarinic Acetylcholine Receptor M4 Distributors

11.3 Muscarinic Acetylcholine Receptor M4 Customer

12 World Forecast Review for Muscarinic Acetylcholine Receptor M4 by Geographic Region

12.1 Global Muscarinic Acetylcholine Receptor M4 Market Size Forecast by Region

12.1.1 Global Muscarinic Acetylcholine Receptor M4 Forecast by Region (2023-2028)

12.1.2 Global Muscarinic Acetylcholine Receptor M4 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Muscarinic Acetylcholine Receptor M4 Forecast by Type

12.7 Global Muscarinic Acetylcholine Receptor M4 Forecast by Application

13 Key Players Analysis

13.1 Anavex Life Sciences Corp

13.1.1 Anavex Life Sciences Corp Company Information

13.1.2 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Offered

13.1.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Anavex Life Sciences Corp Main Business Overview

13.1.5 Anavex Life Sciences Corp Latest Developments

13.2 AstraZeneca Plc

13.2.1 AstraZeneca Plc Company Information

13.2.2 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Offered

13.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Plc Main Business Overview

13.2.5 AstraZeneca Plc Latest Developments

13.3 Heptares Therapeutics Ltd

13.3.1 Heptares Therapeutics Ltd Company Information

13.3.2 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Offered

13.3.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Heptares Therapeutics Ltd Main Business Overview

13.3.5 Heptares Therapeutics Ltd Latest Developments

13.4 Karuna Pharmaceuticals Inc

13.4.1 Karuna Pharmaceuticals Inc Company Information

13.4.2 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Offered

13.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Karuna Pharmaceuticals Inc Main Business Overview

13.4.5 Karuna Pharmaceuticals Inc Latest Developments

13.5 NeuroHealing Pharmaceuticals Inc

13.5.1 NeuroHealing Pharmaceuticals Inc Company Information

13.5.2 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Offered

13.5.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 NeuroHealing Pharmaceuticals Inc Main Business Overview

13.5.5 NeuroHealing Pharmaceuticals Inc Latest Developments

13.6 Sumitomo Dainippon Pharma Co Ltd

13.6.1 Sumitomo Dainippon Pharma Co Ltd Company Information

13.6.2 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Offered

13.6.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sumitomo Dainippon Pharma Co Ltd Main Business Overview

13.6.5 Sumitomo Dainippon Pharma Co Ltd Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Muscarinic Acetylcholine Receptor M4 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Muscarinic Acetylcholine Receptor M4 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tropicamide

Table 4. Major Players of ANAVEX-273

Table 5. Major Players of VU-0467154

Table 6. Major Players of Others

Table 7. Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2017-2022)

Table 9. Global Muscarinic Acetylcholine Receptor M4 Revenue by Type (2017-2022) & ($ million)

Table 10. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type (2017-2022)

Table 11. Global Muscarinic Acetylcholine Receptor M4 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2017-2022)

Table 14. Global Muscarinic Acetylcholine Receptor M4 Revenue by Application (2017-2022)

Table 15. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application (2017-2022)

Table 16. Global Muscarinic Acetylcholine Receptor M4 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Muscarinic Acetylcholine Receptor M4 Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Company (2020-2022)

Table 19. Global Muscarinic Acetylcholine Receptor M4 Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Company (2020-2022)

Table 21. Global Muscarinic Acetylcholine Receptor M4 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Muscarinic Acetylcholine Receptor M4 Producing Area Distribution and Sales Area

Table 23. Players Muscarinic Acetylcholine Receptor M4 Products Offered

Table 24. Muscarinic Acetylcholine Receptor M4 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Muscarinic Acetylcholine Receptor M4 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share Geographic Region (2017-2022)

Table 29. Global Muscarinic Acetylcholine Receptor M4 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Muscarinic Acetylcholine Receptor M4 Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country/Region (2017-2022)

Table 33. Global Muscarinic Acetylcholine Receptor M4 Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Muscarinic Acetylcholine Receptor M4 Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country (2017-2022)

Table 37. Americas Muscarinic Acetylcholine Receptor M4 Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country (2017-2022)

Table 39. Americas Muscarinic Acetylcholine Receptor M4 Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2017-2022)

Table 41. Americas Muscarinic Acetylcholine Receptor M4 Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2017-2022)

Table 43. APAC Muscarinic Acetylcholine Receptor M4 Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2017-2022)

Table 45. APAC Muscarinic Acetylcholine Receptor M4 Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Region (2017-2022)

Table 47. APAC Muscarinic Acetylcholine Receptor M4 Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2017-2022)

Table 49. APAC Muscarinic Acetylcholine Receptor M4 Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2017-2022)

Table 51. Europe Muscarinic Acetylcholine Receptor M4 Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country (2017-2022)

Table 53. Europe Muscarinic Acetylcholine Receptor M4 Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country (2017-2022)

Table 55. Europe Muscarinic Acetylcholine Receptor M4 Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2017-2022)

Table 57. Europe Muscarinic Acetylcholine Receptor M4 Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Muscarinic Acetylcholine Receptor M4

Table 68. Key Market Challenges & Risks of Muscarinic Acetylcholine Receptor M4

Table 69. Key Industry Trends of Muscarinic Acetylcholine Receptor M4

Table 70. Muscarinic Acetylcholine Receptor M4 Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Muscarinic Acetylcholine Receptor M4 Distributors List

Table 73. Muscarinic Acetylcholine Receptor M4 Customer List

Table 74. Global Muscarinic Acetylcholine Receptor M4 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Muscarinic Acetylcholine Receptor M4 Sales Market Forecast by Region

Table 76. Global Muscarinic Acetylcholine Receptor M4 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Muscarinic Acetylcholine Receptor M4 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Muscarinic Acetylcholine Receptor M4 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Muscarinic Acetylcholine Receptor M4 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Muscarinic Acetylcholine Receptor M4 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Muscarinic Acetylcholine Receptor M4 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Muscarinic Acetylcholine Receptor M4 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Muscarinic Acetylcholine Receptor M4 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Muscarinic Acetylcholine Receptor M4 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Muscarinic Acetylcholine Receptor M4 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Muscarinic Acetylcholine Receptor M4 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share Forecast by Application (2023-2028)

Table 94. Anavex Life Sciences Corp Basic Information, Muscarinic Acetylcholine Receptor M4 Manufacturing Base, Sales Area and Its Competitors

Table 95. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Offered

Table 96. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Anavex Life Sciences Corp Main Business

Table 98. Anavex Life Sciences Corp Latest Developments

Table 99. AstraZeneca Plc Basic Information, Muscarinic Acetylcholine Receptor M4 Manufacturing Base, Sales Area and Its Competitors

Table 100. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Offered

Table 101. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. AstraZeneca Plc Main Business

Table 103. AstraZeneca Plc Latest Developments

Table 104. Heptares Therapeutics Ltd Basic Information, Muscarinic Acetylcholine Receptor M4 Manufacturing Base, Sales Area and Its Competitors

Table 105. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Offered

Table 106. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Heptares Therapeutics Ltd Main Business

Table 108. Heptares Therapeutics Ltd Latest Developments

Table 109. Karuna Pharmaceuticals Inc Basic Information, Muscarinic Acetylcholine Receptor M4 Manufacturing Base, Sales Area and Its Competitors

Table 110. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Offered

Table 111. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Karuna Pharmaceuticals Inc Main Business

Table 113. Karuna Pharmaceuticals Inc Latest Developments

Table 114. NeuroHealing Pharmaceuticals Inc Basic Information, Muscarinic Acetylcholine Receptor M4 Manufacturing Base, Sales Area and Its Competitors

Table 115. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Offered

Table 116. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. NeuroHealing Pharmaceuticals Inc Main Business

Table 118. NeuroHealing Pharmaceuticals Inc Latest Developments

Table 119. Sumitomo Dainippon Pharma Co Ltd Basic Information, Muscarinic Acetylcholine Receptor M4 Manufacturing Base, Sales Area and Its Competitors

Table 120. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Offered

Table 121. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Sumitomo Dainippon Pharma Co Ltd Main Business

Table 123. Sumitomo Dainippon Pharma Co Ltd Latest Developments

List of Figures

Figure 1. Picture of Muscarinic Acetylcholine Receptor M4

Figure 2. Muscarinic Acetylcholine Receptor M4 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Muscarinic Acetylcholine Receptor M4 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Muscarinic Acetylcholine Receptor M4 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Muscarinic Acetylcholine Receptor M4 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tropicamide

Figure 10. Product Picture of ANAVEX-273

Figure 11. Product Picture of VU-0467154

Figure 12. Product Picture of Others

Figure 13. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type in 2021

Figure 14. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type (2017-2022)

Figure 15. Muscarinic Acetylcholine Receptor M4 Consumed in Cognitive Disorders

Figure 16. Global Muscarinic Acetylcholine Receptor M4 Market: Cognitive Disorders (2017-2022) & (K Pcs)

Figure 17. Muscarinic Acetylcholine Receptor M4 Consumed in Psychosis

Figure 18. Global Muscarinic Acetylcholine Receptor M4 Market: Psychosis (2017-2022) & (K Pcs)

Figure 19. Muscarinic Acetylcholine Receptor M4 Consumed in Amnesia

Figure 20. Global Muscarinic Acetylcholine Receptor M4 Market: Amnesia (2017-2022) & (K Pcs)

Figure 21. Muscarinic Acetylcholine Receptor M4 Consumed in Others

Figure 22. Global Muscarinic Acetylcholine Receptor M4 Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2017-2022)

Figure 24. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application in 2021

Figure 25. Muscarinic Acetylcholine Receptor M4 Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Company in 2021

Figure 27. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Geographic Region in 2021

Figure 29. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2017-2022)

Figure 30. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country/Region in 2021

Figure 31. Americas Muscarinic Acetylcholine Receptor M4 Sales 2017-2022 (K Pcs)

Figure 32. Americas Muscarinic Acetylcholine Receptor M4 Revenue 2017-2022 ($ Millions)

Figure 33. APAC Muscarinic Acetylcholine Receptor M4 Sales 2017-2022 (K Pcs)

Figure 34. APAC Muscarinic Acetylcholine Receptor M4 Revenue 2017-2022 ($ Millions)

Figure 35. Europe Muscarinic Acetylcholine Receptor M4 Sales 2017-2022 (K Pcs)

Figure 36. Europe Muscarinic Acetylcholine Receptor M4 Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Revenue 2017-2022 ($ Millions)

Figure 39. Americas Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country in 2021

Figure 40. Americas Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country in 2021

Figure 41. United States Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region in 2021

Figure 46. APAC Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Regions in 2021

Figure 47. China Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country in 2021

Figure 54. Europe Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country in 2021

Figure 55. Germany Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Country in 2021

Figure 62. Egypt Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Muscarinic Acetylcholine Receptor M4 Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Muscarinic Acetylcholine Receptor M4 in 2021

Figure 68. Manufacturing Process Analysis of Muscarinic Acetylcholine Receptor M4

Figure 69. Industry Chain Structure of Muscarinic Acetylcholine Receptor M4

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390